Study at v1.0.0
NCT00040378
5b335689d611f1cb66c5bbc8a5fdb0f9c6fb9261004a694464c0b053d7bf0bbf · where else it appears
Data
{
"briefSummary": "The Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) prevention trial is an important addition to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). As a prevention trial, PREADVISE is trying to find out if taking selenium and/or Vitamin E supplements can help to prevent memory loss and dementia such as Alzheimer's disease.",
"completionDate": "2016-08",
"conditions": [
"Alzheimer Disease"
],
"enrollmentCount": 4246,
"enrollmentType": "ACTUAL",
"nctId": "NCT00040378",
"phase": null,
"sponsorId": "frederick-schmitt",
"startDate": "2002-05",
"status": "COMPLETED",
"studyType": "OBSERVATIONAL",
"title": "Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)",
"url": "https://clinicaltrials.gov/study/NCT00040378"
}History in this collection
- addedv1.0.0Jun 12, 2026this version